Hepatitis: Drugs

Department of Health written question – answered on 3rd July 2015.

Alert me about debates like this

Photo of Grahame Morris Grahame Morris Labour, Easington

To ask the Secretary of State for Health, what representations he has received from NICE on the timely implementation of its recommendations on the availability of new drugs for the treatment of Hepatitis C.

Photo of George Freeman George Freeman The Parliamentary Under-Secretary of State for Business, Innovation and Skills, The Parliamentary Under-Secretary of State for Health

The National Institute for Health and Care Excellence (NICE) published final technology appraisal guidance in February 2015 recommending the hepatitis C drugs sofosbuvir (Sovaldi) and simeprevir (Olysio) for patients meeting specified clinical criteria. The Department has received no subsequent representations from NICE about the implementation of its guidance on these treatments.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.